Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure. - Wikidata - wikimedia - TriplyDB

Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure.

Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure.

http://www.wikidata.org/entity/Q37077866

about

Targeting heart failure with preserved ejection fraction: current status and future prospects Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age ≥ 65 years.A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010 Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Treatment of heart failure with preserved ejection fraction.Managing comorbidities in patients with chronic heart failure: first, do no harm.The clinical dilemma of heart failure with preserved ejection fraction: an update on pathophysiology and management for physicians.

P2860

Q26752956-6CD3E689-BB43-47A1-A798-174015AA5EF7 Q26796271-5A453AD0-8762-4212-976C-B6DB623397FD Q33578694-8B5C6E03-58EB-4F26-9B45-A6404C466845 Q34647669-C983870A-3EF8-4DA6-ABD9-C9F91EFA849B Q35883274-9CF49834-E4F4-4512-BB8A-6D239CC54909 Q35885001-685584B7-0D21-4EB4-A4BF-C840EC3DA7DF Q36077080-96A39A71-7FFF-4B4A-9266-6EAB684ADE06 Q36419969-D4264797-B57B-4ECD-90FE-DD5B45A8AA99 Q37292234-F57CF692-4019-4BAE-8113-6AB6474788A3 Q37848405-BDCA9E8A-9937-4325-B8D5-A94226544FFA Q38402807-C41F470A-97D7-4156-953D-A9095193629E Q38768799-314D8611-C7A7-4DD8-B592-A3962D6461CC

P2860

Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure.

http://www.wikidata.org/entity/Q37077866

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Digoxin and reduction of heart ...... c and diastolic heart failure.

@en

Digoxin and reduction of heart ...... c and diastolic heart failure.

@nl

type

label

Digoxin and reduction of heart ...... c and diastolic heart failure.

@en

Digoxin and reduction of heart ...... c and diastolic heart failure.

@nl

prefLabel

Digoxin and reduction of heart ...... c and diastolic heart failure.

@en

Digoxin and reduction of heart ...... c and diastolic heart failure.

@nl

P1433

Q37077866-2EE233B3-B511-4067-9D1C-6EBB6795344C

P1476

Q37077866-5F91A154-71D9-469F-967B-8E5D13A913C4

P2093

Q37077866-1EC14108-9B5C-493F-ACC5-8DFDA628B2F1

Q37077866-5C2590B1-EFD9-498C-97A0-AB4290A3D23B

Q37077866-7C3B07A3-6BEF-4B29-A2ED-76A920362CA7

Q37077866-7EE641A0-AABA-413C-8227-D95D30C79B14

Q37077866-969B46F7-9F65-4474-9AF0-1001DB2FD16C

Q37077866-A59B1ED4-3098-4FC5-8AF7-AAA9EC36FD4B

Q37077866-BDF67916-9FA8-4D06-AF25-F637404BBB16

Q37077866-C2AD6CB0-62A4-4CB4-8633-66A4A589E9C4

Q37077866-CCE68975-289E-4853-8DC3-20EDFAFD0245

P2860

Q37077866-037F98D7-603E-4593-ABBD-C171F3FC69A1

Q37077866-0752A283-F71C-4EAC-9EC8-652F26196663

Q37077866-15C6015E-47BB-4793-8B3F-D2511C58198A

Q37077866-1E4D9BCE-319E-4BB8-A9F8-C84F1613A7F2

Q37077866-299B0F0A-736B-4C4D-9400-0B81597404F9

Q37077866-56C57543-D817-46CA-BE87-69FC4D9B530A

Q37077866-58DBB842-370F-4857-992D-04336D166C03

Q37077866-A7EE7EAC-B3A8-4A8B-BB50-16D2991DD648

Q37077866-B22EEA45-13C3-4995-83AA-7F40AE35D235

Q37077866-D5BC840A-2ADE-41A8-83B1-944659CBA3FF

P304

Q37077866-D015B29F-F937-4E31-973A-C8A7035A4174

P31

Q37077866-14860F5E-8F69-45E4-80CF-0DFDC76A5FE2

P356

Q37077866-C0BFD9E4-FA63-4958-851A-F54D09983960

P407

Q37077866-9492690C-80B7-4561-B305-4D88CB109A9E

P433

Q37077866-A027AB92-EE48-4DFE-957E-2DA7602A8852

P478

Q37077866-7E747CD3-C654-45E2-BD15-AF46E414D9F5

P577

Q37077866-E6B94856-9952-4F9A-9339-FBDFAB91D889

P5875

Q37077866-D67482CA-BEF3-4A53-84DA-364C4D8BAB49

P698

Q37077866-E1EB1539-044B-4518-B68A-CE0D6586BC9B

P921

Q37077866-1D2A0E01-EDAC-4F45-9765-B1492197BD0D

Q37077866-440E080F-62DE-4235-8DF1-5960EB7F0603

Q37077866-7B76B19E-157E-4344-9AE7-D1CA7F731AC1

Q37077866-B321E99E-5737-4F85-A318-C5481FB9CC61

Q37077866-FD3A2E4C-8273-41AD-8C18-F91EE4B6E9C9

P932

Q37077866-4290C1F0-09C2-422A-957C-01BEB3675FD0

P356

J.AMJCARD.2008.05.068

P1433

American Journal of Cardiology

P1476

Digoxin and reduction of heart ...... c and diastolic heart failure.

@en

P2093

Ali Ahmed

http://www.w3.org/2001/XMLSchema#string

Anna Nozza

http://www.w3.org/2001/XMLSchema#string

Inmaculada Aban

http://www.w3.org/2001/XMLSchema#string

James B Young

http://www.w3.org/2001/XMLSchema#string

Marjan Mujib

http://www.w3.org/2001/XMLSchema#string

Michel White

http://www.w3.org/2001/XMLSchema#string

Philippe Meyer

http://www.w3.org/2001/XMLSchema#string

Thomas E Love

http://www.w3.org/2001/XMLSchema#string

William H Wehrmacher

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of heart failure with preserved ejection fraction in a population-based study

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

Acute heart failure syndromes: current state and framework for future research.

The underuse of digoxin in heart failure, and approaches to appropriate use.

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis.

Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

P304

1681-1686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2008.05.068

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23639420

http://www.w3.org/2001/XMLSchema#string

P698

19064024

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization

P932

2633091

http://www.w3.org/2001/XMLSchema#string